Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Twelve weeks of smoking cessation therapy with varenicline increases the serum levels of apolipoprotein A-I only in the success group.

Iwaoka M, Shimamura H, Tsuji T, Kugiyama K.

J Cardiol. 2014 Oct;64(4):318-23. doi: 10.1016/j.jjcc.2014.02.009. Epub 2014 Mar 24.

2.
3.

Twelve Weeks of Successful Smoking Cessation Therapy with Varenicline Reduces Spirometric Lung Age.

Iwaoka M, Tsuji T.

Intern Med. 2016;55(17):2387-92. doi: 10.2169/internalmedicine.55.6844. Epub 2016 Sep 1.

4.

Impact of cigarette smoking cessation on high-density lipoprotein functionality.

Takata K, Imaizumi S, Kawachi E, Suematsu Y, Shimizu T, Abe S, Matsuo Y, Tsukahara H, Noda K, Yahiro E, Zhang B, Uehara Y, Miura S, Saku K.

Circ J. 2014;78(12):2955-62. Epub 2014 Oct 16.

5.
7.

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ.

Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000.

PMID:
21452908
8.
9.

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.

Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.

Arch Intern Med. 2006 Aug 14-28;166(15):1571-7.

PMID:
16908789
10.

Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.

Bolliger CT, Issa JS, Posadas-Valay R, Safwat T, Abreu P, Correia EA, Park PW, Chopra P.

Clin Ther. 2011 Apr;33(4):465-77. doi: 10.1016/j.clinthera.2011.04.013.

PMID:
21635992
11.

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.

J Clin Psychiatry. 2012 May;73(5):654-60. doi: 10.4088/JCP.11m07522. Erratum in: J Clin Psychiatry. 2012 Jul;73(7):1035.

PMID:
22697191
12.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
15.

Varenicline for smoking cessation: a placebo-controlled, randomized study.

Wang C, Xiao D, Chan KP, Pothirat C, Garza D, Davies S.

Respirology. 2009 Apr;14(3):384-92. doi: 10.1111/j.1440-1843.2008.01476.x. Epub 2009 Feb 20.

PMID:
19192221
16.

Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.

Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C.

Ann Intern Med. 2013 Sep 17;159(6):390-400. doi: 10.7326/0003-4819-159-6-201309170-00005. Erratum in: Ann Intern Med. 2013 Oct 15;159(8):576.

PMID:
24042367
17.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
18.

Predictors of quit success in Belgian participants of a varenicline observational smoking cessation study.

Boudrez H, Hoengenaert JP, Nackaerts K, Messig M, Metcalfe M.

Acta Clin Belg. 2013 Jan-Feb;68(1):37-42. Erratum in: Acta Clin Belg. 2013 May-Jun;68(3):252.

PMID:
23627193
19.

Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial.

Jennings C, Kotseva K, De Bacquer D, Hoes A, de Velasco J, Brusaferro S, Mead A, Jones J, Tonstad S, Wood D; EUROACTION PLUS Study Group..

Eur Heart J. 2014 Jun 1;35(21):1411-20. doi: 10.1093/eurheartj/ehu051. Epub 2014 Mar 9.

PMID:
24616337
20.

Effectiveness of varenicline for smoking cessation: a 1-year follow-up study.

Grassi MC, Enea D, Ferketich AK, Lu B, Pasquariello S, Nencini P.

J Subst Abuse Treat. 2011 Jul;41(1):64-70. doi: 10.1016/j.jsat.2011.01.014. Epub 2011 Feb 23.

PMID:
21349681

Supplemental Content

Support Center